search
Back to results

The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy. (SHOR-TEST)

Primary Purpose

Prostate Cancer

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
High Intensity Interval Training bout
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Prostate Cancer focused on measuring prostate neoplasm, exercise, high intensity interval training, tumor hypoxia, immune cells

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Men with histologically verified localized prostate adenocarcinoma undergoing curative intended radical prostatectomy.

Exclusion Criteria:

  • Age: <18 years
  • Any other known malignancy requiring active treatment
  • Performance status > 1
  • Allergy to pimonidazole
  • Ongoing treatment with beta blockers
  • Physical disabilities precluding physical testing and/or exercise
  • Inability to read and understand Danish

Sites / Locations

  • Center for Physical Activity Research, Copenhagen University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

High Intensity Interval Training bout

Controls (usual care)

Arm Description

Patients randomized to this group will perform a wattmax test immediately followed by 4 intervals of high and low intensity based on percentage of wattmax. Immediately after the exercise bout is finished patients will receive one dose of pimonidazole hydrochloride (500 mg per m2 body surface) in order to quantify tumor hypoxia by pathological analyses after removal of the prostate by radical prostatectomy the following day.

Patients randomized to the control group will not be doing any exercise, but will after approximately 35 min from baseline blood sampling receive one dose of pimonidazole hydrochloride (500 mg per m2 bodysurface) in order to quantify tumor hypoxia by pathological analyses after removal of the prostate by radical prostatectomy the following day.

Outcomes

Primary Outcome Measures

Tumor hypoxia
Quantification of tumor hypoxia will be assessed using pimonidazole staining

Secondary Outcome Measures

Intratumoral immune cell infiltration
Intratumoral immune cell infiltration will be quantified using histological analyses
Tumor vessel morphology
Tumor vessel morphology will be evaluated using histological analyses
Tumor metabolism-, biology and signaling
Tumor samples will undergo proteomic analyses in order to uncover potential upregulated biomarkers
Changes in immune cells during an acute exercise bout
Changes in immune cells during an acute exercise bout will be measured in blood samples using flowcytometry
Changes in epinephrine concentration
Concentration of epinephrine will be measured in blood samples by radioimmunoassay analyses.
Changes in nor-epinephrine concentration
Concentration of nor-epinephrine will be measured in blood samples by radioimmunoassay analyses.
Changes in various interleukines
Concentration of various interleukines will be measured in blood samples by measured in blood samples by Enzyme-Linked Immunosorbent Assay (ELISA) analyses.
Changes in Tumor Necrosis Factor alpha (TNFa) concentration
Concentrations of TNFa will be measured in blood samples by Enzyme-Linked Immunosorbent Assay (ELISA) analyses.
Changes in Interferon Gamma (IFNγ) concentration
Concentrations of IFNγ will be measured in blood samples by Enzyme-Linked Immunosorbent Assay (ELISA) analyses.
Concentration of C-reactive Protein (CRP)
Concentration of CRP will be measured in fasting blood sample by standard laboratory methods.
Total plasma cholesterol concentration
Concentrations of total cholesterol will be measured in fasting blood samples by standard laboratory methods.
Plasma LDL-Cholesterol concentration
Concentrations of LDL- cholesterol will be measured in fasting blood samples by standard laboratory methods.
Plasma HDL-Cholesterol concentration
Concentrations of HDL- cholesterol will be measured in fasting blood samples by standard laboratory methods.
Plasma triglyceride concentrations
Concentrations of triglycerides will be measured in fasting blood samples by standard laboratory methods.
HbA1C concentration
Concentrations of HbA1C will be measured in fasting blood samples by standard laboratory methods.
Plasma Insulin concentration
Concentrations of insulin will be measured in fasting blood samples by standard laboratory methods.
Plasma Glucose concentration
Concentrations of glucose will be measured in fasting blood samples by standard laboratory methods.
Wattmax-test
The participants in the HIIT group will undergo a maximal graded exercise test on a bicycle ergometer for evaluation of cardiovascular function and determination of the maximum watt (wattmax). The test starts with a 3 min warm up at 70 watt (the watts may have to be adjusted to the individual fitness level). Warm up is immediately followed by a 20 watt increase every 1 min until exhaustion. The maximum watt will be calculated.

Full Information

First Posted
August 24, 2018
Last Updated
December 12, 2019
Sponsor
Rigshospitalet, Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT03675529
Brief Title
The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.
Acronym
SHOR-TEST
Official Title
The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy - a Randomized Controlled Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
December 2019
Overall Recruitment Status
Completed
Study Start Date
October 1, 2018 (Actual)
Primary Completion Date
November 24, 2019 (Actual)
Study Completion Date
November 24, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background and purpose: The purpose of this study is to investigate the effect of one acute exercise bout on tumor hypoxia in patients with localized prostate cancer undergoing radical prostatectomy. The primary hypothesis is that exercise reduces tumor hypoxia and that the reduction is greater in patients performing one acute high intensity exercise bout compared to no training controls. The investigators have not been able to identify any prior or current randomized trials investigating exercise and tumor hypoxia, and believe that such research is warranted and would be of great importance. Moreover there is a need for studies including biological measurements to allow a full assessment of the effect of exercise on diverse biomarkers and mechanistic pathways, which may influence cancer survival. Subjects: Patients with histologically verified prostate adenocarcinoma scheduled for radical prostatectomy at Urologic Department, Rigshospitalet, Copenhagen, Denmark. Methods: In this randomized controlled pilot study 30 patients with localized prostate cancer undergoing radical prostatectomy will be included and randomized 2:1 to either one single acute High Intensity Interval Training bout or usual care and no training the day prior to radical prostatectomy. All patients will undergo assessment at inclusion (baseline) and the day prior to surgery. Assessment includes: anthropometrics; blood pressure; resting hearth rate; hip and waist circumference, ECG, quality of life by self-report questionnaires; fasting blood sample measuring PSA (prostate specific antigen), cholesterol, triglycerides, insulin, c-peptide, HbA1c, glucose and inflammatory markers. All patients will receive one dose of pimonidazole hydrochloride (500 mg per m2 body surface) in order to quantify tumor hypoxia by pathological analyses after removal of the prostate. Biological tissue from tumor (primary prostate biopsies) will also be retrieved from the respective local pathological departments and from the perioperative prostate specimen and sent to protocol analyses.
Detailed Description
The purpose of this study is to investigate the effect of one acute exercise bout on tumor hypoxia in patients with localized prostate cancer randomized to one single acute I) High Intensity Interval Training bout compared to (II) usual care and no training prior to radical prostatectomy. In addition to this the aim is to investigate the effect of one exercise bout on tumor vessel morphology and to investigate the effect of one acute exercise bout on intratumoral immune cell infiltration and to investigate the modulation of tumor-metabolism, -biology and signaling in patients randomized to either one acute High Intensity Interval Training bout compared to usual care and no training, the day prior to surgery. Moreover this study will explore the acute response in immune cells, hormones and cytokines in blood samples taken before, during and after a single exercise session, and will collect physiological (metabolic profile and metabolic inflammatory markers) and psycho-social (e.g. fatigue, emotional well-being, anxiety) information regarding patients randomized to either one acute High Intensity Interval Training bout compared to usual care and no training, the day prior to surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer
Keywords
prostate neoplasm, exercise, high intensity interval training, tumor hypoxia, immune cells

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
High Intensity Interval Training bout
Arm Type
Experimental
Arm Description
Patients randomized to this group will perform a wattmax test immediately followed by 4 intervals of high and low intensity based on percentage of wattmax. Immediately after the exercise bout is finished patients will receive one dose of pimonidazole hydrochloride (500 mg per m2 body surface) in order to quantify tumor hypoxia by pathological analyses after removal of the prostate by radical prostatectomy the following day.
Arm Title
Controls (usual care)
Arm Type
No Intervention
Arm Description
Patients randomized to the control group will not be doing any exercise, but will after approximately 35 min from baseline blood sampling receive one dose of pimonidazole hydrochloride (500 mg per m2 bodysurface) in order to quantify tumor hypoxia by pathological analyses after removal of the prostate by radical prostatectomy the following day.
Intervention Type
Behavioral
Intervention Name(s)
High Intensity Interval Training bout
Intervention Description
Patients randomized to the HIIT bout will perform one single supervised High Intensity Interval Training bout consisting firstly of a wattmax test on a stationary bike, in order to set the training intensity. This is followed by 10 minutes at low intensity at approximately 30% of wattmax. Subsequently patients will perform 16 min with 4 cycles with High and Low intensity. HI intervals consisting of 1 min with 100% of wattmax followed by 3 min recovery with the intensity load of 30% of wattmax.
Primary Outcome Measure Information:
Title
Tumor hypoxia
Description
Quantification of tumor hypoxia will be assessed using pimonidazole staining
Time Frame
At prostatectomy
Secondary Outcome Measure Information:
Title
Intratumoral immune cell infiltration
Description
Intratumoral immune cell infiltration will be quantified using histological analyses
Time Frame
Primary prostate biopsies and until radical prostatectomy
Title
Tumor vessel morphology
Description
Tumor vessel morphology will be evaluated using histological analyses
Time Frame
Primary prostate biopsies and until radical prostatectomy
Title
Tumor metabolism-, biology and signaling
Description
Tumor samples will undergo proteomic analyses in order to uncover potential upregulated biomarkers
Time Frame
Primary prostate biopsies and until radical prostatectomy
Title
Changes in immune cells during an acute exercise bout
Description
Changes in immune cells during an acute exercise bout will be measured in blood samples using flowcytometry
Time Frame
From start of exercise bout and until 60 minutes post exercise
Title
Changes in epinephrine concentration
Description
Concentration of epinephrine will be measured in blood samples by radioimmunoassay analyses.
Time Frame
From start of exercise bout and until 60 minutes post exercise
Title
Changes in nor-epinephrine concentration
Description
Concentration of nor-epinephrine will be measured in blood samples by radioimmunoassay analyses.
Time Frame
From start of exercise bout and until 60 minutes post exercise
Title
Changes in various interleukines
Description
Concentration of various interleukines will be measured in blood samples by measured in blood samples by Enzyme-Linked Immunosorbent Assay (ELISA) analyses.
Time Frame
From start of exercise bout and until 60 minutes post exercise
Title
Changes in Tumor Necrosis Factor alpha (TNFa) concentration
Description
Concentrations of TNFa will be measured in blood samples by Enzyme-Linked Immunosorbent Assay (ELISA) analyses.
Time Frame
From start of exercise bout and until 60 minutes post exercise
Title
Changes in Interferon Gamma (IFNγ) concentration
Description
Concentrations of IFNγ will be measured in blood samples by Enzyme-Linked Immunosorbent Assay (ELISA) analyses.
Time Frame
From start of exercise bout and until 60 minutes post exercise
Title
Concentration of C-reactive Protein (CRP)
Description
Concentration of CRP will be measured in fasting blood sample by standard laboratory methods.
Time Frame
Blood sampling on the day of radical prostatectomy
Title
Total plasma cholesterol concentration
Description
Concentrations of total cholesterol will be measured in fasting blood samples by standard laboratory methods.
Time Frame
Blood sampling on the day of radical prostatectomy
Title
Plasma LDL-Cholesterol concentration
Description
Concentrations of LDL- cholesterol will be measured in fasting blood samples by standard laboratory methods.
Time Frame
Blood sampling on the day of radical prostatectomy
Title
Plasma HDL-Cholesterol concentration
Description
Concentrations of HDL- cholesterol will be measured in fasting blood samples by standard laboratory methods.
Time Frame
Blood sampling on the day of radical prostatectomy
Title
Plasma triglyceride concentrations
Description
Concentrations of triglycerides will be measured in fasting blood samples by standard laboratory methods.
Time Frame
Blood sampling on the day of radical prostatectomy
Title
HbA1C concentration
Description
Concentrations of HbA1C will be measured in fasting blood samples by standard laboratory methods.
Time Frame
Blood sampling on the day of radical prostatectomy
Title
Plasma Insulin concentration
Description
Concentrations of insulin will be measured in fasting blood samples by standard laboratory methods.
Time Frame
Blood sampling on the day of radical prostatectomy
Title
Plasma Glucose concentration
Description
Concentrations of glucose will be measured in fasting blood samples by standard laboratory methods.
Time Frame
Blood sampling on the day of radical prostatectomy
Title
Wattmax-test
Description
The participants in the HIIT group will undergo a maximal graded exercise test on a bicycle ergometer for evaluation of cardiovascular function and determination of the maximum watt (wattmax). The test starts with a 3 min warm up at 70 watt (the watts may have to be adjusted to the individual fitness level). Warm up is immediately followed by a 20 watt increase every 1 min until exhaustion. The maximum watt will be calculated.
Time Frame
At baseline assessment

10. Eligibility

Sex
Male
Gender Based
Yes
Gender Eligibility Description
Men with prostate cancer
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men with histologically verified localized prostate adenocarcinoma undergoing curative intended radical prostatectomy. Exclusion Criteria: Age: <18 years Any other known malignancy requiring active treatment Performance status > 1 Allergy to pimonidazole Ongoing treatment with beta blockers Physical disabilities precluding physical testing and/or exercise Inability to read and understand Danish
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sissal S Djurhuus, MD
Organizational Affiliation
PhD student
Official's Role
Principal Investigator
Facility Information:
Facility Name
Center for Physical Activity Research, Copenhagen University Hospital
City
Copenhagen
ZIP/Postal Code
DK-2100
Country
Denmark

12. IPD Sharing Statement

Citations:
PubMed Identifier
36199257
Citation
Djurhuus SS, Schauer T, Simonsen C, Toft BG, Jensen ARD, Erler JT, Roder MA, Hojman P, Brasso K, Christensen JF. Effects of acute exercise training on tumor outcomes in men with localized prostate cancer: A randomized controlled trial. Physiol Rep. 2022 Oct;10(19):e15408. doi: 10.14814/phy2.15408.
Results Reference
derived
PubMed Identifier
36133956
Citation
Schauer T, Djurhuus SS, Simonsen C, Brasso K, Christensen JF. The effects of acute exercise and inflammation on immune function in early-stage prostate cancer. Brain Behav Immun Health. 2022 Sep 7;25:100508. doi: 10.1016/j.bbih.2022.100508. eCollection 2022 Nov.
Results Reference
derived

Learn more about this trial

The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.

We'll reach out to this number within 24 hrs